Egypt Rameda's shareholders approve capital raise via bonus issue
The company will distribute 0.30 bonus share for every original share
Traders work at the Egyptian stock exchange in Cairo, Egypt April 18, 2016.
REUTERS/Mohamed Abd El Ghany
By Staff Writer, Mubasher
Cairo – The ordinary general meeting (OGM) of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) approved the board’s proposal to distribute bonus shares worth EGP 57.8 million to shareholders for 2020.
The company will distribute 0.30 bonus share for every original share to be funded from the company’s distributable profits, according to a bourse disclosure on Monday.
Following the rise, the company’s issued capital will be increased to EGP 250 million, distributed over 1 billion shares at a value of EGP 0.25 apiece.
During 2020, Rameda recorded net profits of EGP 111.51 million, up from EGP 81.67 million a year earlier, including minority shareholders’ rights.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.